Pharmaceutical Formulation Development
YOUR COMPOUND IN THE CLINIC. QUICKLY. COST-EFFECTIVELY. END OF STORY.
Why choose Metrics for the development and manufacture of your critical compounds? The answer is easy, once you know the Metrics difference.
THE METRICS DIFFERENCE
- A pharmaceutical development staff with an average of 16 years' career experience
- Advanced scientific expertise from PhDs, Master and Registered Pharmacists and Chemists
- Flexible, state-of-the-art manufacturing facility and equipment
- Potent and toxic drug handling capabilities
- DEA-registered for Schedule II-V
- cGMP Facility with excellent FDA track record
- Analytical support from over 80 chemists
AND WHAT IT MEANS FOR YOU
- You’ll receive experienced and timely recommendations and decision-making regarding:
- insoluble actives
- unstable actives
- potent and toxic actives
- small molecule delivery
- large molecule delivery (oral dosage only)
- insoluble actives
- Fast-track development from NCE to first-in-man in 4 to 6 months
- Metrics SOPs can be used for all phases of the FDA submission process
- Seamless scale-up to commercial manufacture
- Batch sizes of less that 1 kg up to 400 kg
- One-on-one, direct communication with project scientists
- Fast-track development for Phase I-III
Clinical Trial Materials (Phase I - III)
- tablets
- capsules
- bead-filled capsules (nonpareil and extruded)
- overencapsulation
- liquid-filled hard gels, for Phase I
- creams, ointments, liquids for Phase I
Final Formulation Expertise in:
- immediate release
- sustained release
- matrix tablets/capsules
- coated tablets
- coated beads
- fast dissolve
- chewable tablets
- soft gels
- extrusion and spheronization
Ready to learn more? Click
here to request more information, or to be contacted
about your specific needs.
